Logo image
Histopathologic Evaluation and Scoring of Viral Lung Infection
Journal article   Open access

Histopathologic Evaluation and Scoring of Viral Lung Infection

David K Meyerholz and Amanda P Beck
Methods in molecular biology (Clifton, N.J.), Vol.2099, pp.205-220
2020
DOI: 10.1007/978-1-0716-0211-9_16
PMCID: PMC7123785
PMID: 31883098
url
https://doi.org/10.1007/978-1-0716-0211-9_16View
Published (Version of record) Open Access

Abstract

Emergent coronaviruses such as MERS-CoV and SARS-CoV can cause significant morbidity and mortality in infected individuals. Lung infection is a common clinical feature and contributes to disease severity as well as viral transmission. Animal models are often required to study viral infections and therapies, especially during an initial outbreak. Histopathology studies allow for identification of lesions and affected cell types to better understand viral pathogenesis and clarify effective therapies. Use of immunostaining allows detection of presumed viral receptors and viral tropism for cells can be evaluated to correlate with lesions. In the lung, lesions and immunostaining can be qualitatively described to define the cell types, microanatomic location, and type of changes seen. These features are important and necessary, but this approach can have limitations when comparing treatment groups. Semiquantitative and quantitative tissue scores are more rigorous as these provide the ability to statistically compare groups and increase the reproducibility and rigor of the study. This review describes principles, approaches, and resources that can be useful to evaluate coronavirus lung infection, focusing on MER-CoV infection as the principal example.
Animals Coronavirus Infections - pathology Coronavirus Infections - virology Humans Lung - pathology Lung - virology Mice Middle East Respiratory Syndrome Coronavirus - physiology Reproducibility of Results Respiratory Tract Infections - pathology Respiratory Tract Infections - virology Viral Tropism

Details

Metrics

Logo image